12 Health Care Stocks Moving In Wednesday’s After-Market Session
Gainers Holdco Nuvo Group DG (NASDAQ:NUVO) shares increased by 21.5% to $1.92 during Wednesday’s after-market session. The company’s…
12 Health Care Stocks Moving In Wednesday’s Intraday Session
Gainers MaxCyte (NASDAQ:MXCT) shares rose 26.5% to $4.97 during Wednesday’s regular session. The company’s market cap stands at…
Vigil Presents Key Findings From ILLUMINATE & IGNITE Studies In ALSP At The 2024 American Academy Of Neurology Annual Meeting
- Findings from ILLUMINATE Natural History Study show that MRI and fluid biomarkers are emerging as key measures of ALSP pathophysiology -- Positive interim IGNITE Phase 2 data demonstrating iluzanebart (VGL101) as
12 Health Care Stocks Moving In Monday’s After-Market Session
Gainers Syra Health (NASDAQ:SYRA) shares rose 21.2% to $1.5 during Monday’s after-market session. The market value of their…
Why Is Rare Neurological Disease Focused Vigil Neuroscience Stock Trading Lower Today?
Vigil Neuroscience Inc (NASDAQ: VIGL) shares are down after the company released interim data from its Phase 2 IGNITE proof-of-concept clinical trial in patients with adult-onset leukoencephalopathy with axonal spheroids and pigmented glia (ALSP), a neurological condition characterized by changes to&nb
Why Dolby Laboratories Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Friday’s Mid-Day Session
Shares of Dolby Laboratories, Inc. (NYSE: DLB) fell during Friday’s session following weak guidance.
12 Health Care Stocks Moving In Friday’s Intraday Session
Gainers Altamira Therapeutics (NASDAQ:CYTO) stock increased by 222.5% to $0.32 during Friday’s regular session. As of 12:31 EST,…
US Stocks Edge Lower; Housing Starts Rise In October
U.S. stocks traded slightly lower this morning, with the Nasdaq Composite falling around 30 points on Friday.
Following the market opening Friday, the Dow traded down 0.04% to 34,931.47 while the NASDAQ fell 0.22% to 14,082.87. The S&P 500 also fell, dropping, 0.07% to 4,504.96.
Vigil Neuroscience’s Focus On Neurodegenerative Diseases: Analyst Says Pipeline Offers Upside Opportunities To Valuation
JMP Securities has initiated coverage on Vigil Neuroscience Inc (NASDAQ: VIGL), noting the company's focus on neurodegenerative diseases.
Benzinga’s Top Ratings Upgrades, Downgrades For October 18, 2023
Upgrades According to National Bank Financial Inc, the prior rating for Brookfield Infrastructure Partners LP (NYSE:BIP) was changed…